5-Hydroxypyridine-2-carboxylic acid → 3-Butyl-8-chloro-1-{4-[5-(5-hydroxy-2-pyridinyl)-1,2,4-oxadiazol-3-yl]butyl}-3,7-dihydro-1H-purine-2,6-dione
Reaction equation
[OH:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]([OH:10])=O)=[N:6][CH:7]=1.[CH2:11]([N:15]1[C:23]2[N:22]=[C:21]([Cl:24])[NH:20][C:19]=2[C:18](=[O:25])[N:17]([CH2:26][CH2:27][CH2:28][CH2:29]/[C:30](=[N:33]/[H])/[NH:31]O)[C:16]1=[O:35])[CH2:12][CH2:13][CH3:14]>CS(C)=O>[CH2:11]([N:15]1[C:23]2[N:22]=[C:21]([Cl:24])[NH:20][C:19]=2[C:18](=[O:25])[N:17]([CH2:26][CH2:27][CH2:28][CH2:29][C:30]2[N:31]=[C:8]([C:5]3[CH:4]=[CH:3][C:2]([OH:1])=[CH:7][N:6]=3)[O:10][N:33]=2)[C:16]1=[O:35])[CH2:12][CH2:13][CH3:14]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 90 °C
Procedure
5-Hydroxy-2-pyridinecarboxylic acid (24 mg, 0.17 mmol) and CDl (31 mg, 0.19 mmol) were stirred in anhydrous DMSO (0.9 ml) at rt for 1 h. (1Z)-5-(3-Butyl-8-chloro-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)-N-hydroxypentanimidamide (68 mg, 0.19 mmol) was added and the mixture was stirred at 90° C. for 16 h. The mixture was purified by MDAP and the product fractions concentrated to give the title compound as a white solid (19 mg, 24%).
Workup
- additionwas added
- customThe mixture was purified by MDAP
- concentrationthe product fractions concentrated
Sources & evidence
- ORD record
- ord-f77cc7c8d48744278faf0b7fdd4ce6d3
- Source dataset
- uspto-grants-2012_03
- Patent number
- US08143264B2
Reaction notes
Loading…